Adtalem Global Education (NYSE:CVSA) CEO Stephen Beard Sells 2,762 Shares

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 2,762 shares of Adtalem Global Education stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $130.14, for a total value of $359,446.68. Following the completion of the transaction, the chief executive officer owned 426,562 shares in the company, valued at approximately $55,512,778.68. This represents a 0.64% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Trading Down 2.8%

Adtalem Global Education stock traded down $3.66 during midday trading on Friday, reaching $128.23. The company’s stock had a trading volume of 295,964 shares, compared to its average volume of 254,545. Adtalem Global Education Inc. has a 52 week low of $86.97 and a 52 week high of $156.26. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36. The firm’s 50-day moving average is $120.70. The firm has a market cap of $4.36 billion, a PE ratio of 16.87, a PEG ratio of 1.09 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last released its earnings results on Thursday, May 7th. The company reported $1.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The firm had revenue of $487.03 million for the quarter. During the same quarter in the prior year, the firm earned $1.92 EPS. The business’s revenue was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, research analysts predict that Adtalem Global Education Inc. will post 8.04 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Zacks Research cut Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Wall Street Zen cut Adtalem Global Education from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Weiss Ratings restated a “hold (c+)” rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Truist Financial boosted their price target on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Finally, Barrington Research restated an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a report on Monday. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.